Literature DB >> 20504221

Should cause of death from the death certificate be used to examine cancer-specific survival? A study of patients with distant stage disease.

Jennifer L Lund1, Linda C Harlan, K Robin Yabroff, Joan L Warren.   

Abstract

Death certificates are used to classify cause of death for studies of cancer survival and mortality. Using data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program, we evaluated cause of death (site-specific, cancer cause-specific, or other cause of death) for 229,181 patients with distant stage disease during 1994-2003 who died by 2005. Agreement between coded cause of death and initial diagnosis was 85% in patients with only one primary and 64% in patients with more than one primary. Our findings support the usefulness of site and cancer cause-specific causes of death reported on the death certificate for distant stage patients with a single cancer.

Entities:  

Mesh:

Year:  2010        PMID: 20504221      PMCID: PMC3097383          DOI: 10.3109/07357901003630959

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  16 in total

Review 1.  Cause of death in clinical research: time for a reassessment?

Authors:  M S Lauer; E H Blackstone; J B Young; E J Topol
Journal:  J Am Coll Cardiol       Date:  1999-09       Impact factor: 24.094

2.  Accuracy of death certificates for coding coronary heart disease as the cause of death.

Authors:  D M Lloyd-Jones; D O Martin; M G Larson; D Levy
Journal:  Ann Intern Med       Date:  1998-12-15       Impact factor: 25.391

3.  The accuracy of liver cancer as the underlying cause of death on death certificates.

Authors:  C Percy; L G Ries; V D Van Holten
Journal:  Public Health Rep       Date:  1990 Jul-Aug       Impact factor: 2.792

4.  Multiple cancer prevalence: a growing challenge in long-term survivorship.

Authors:  Angela B Mariotto; Julia H Rowland; Lynn A G Ries; Steve Scoppa; Eric J Feuer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

5.  Survival associated with treatment vs observation of localized prostate cancer in elderly men.

Authors:  Yu-Ning Wong; Nandita Mitra; Gary Hudes; Russell Localio; J Sanford Schwartz; Fei Wan; Chantal Montagnet; Katrina Armstrong
Journal:  JAMA       Date:  2006-12-13       Impact factor: 56.272

6.  Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: an example from the Mayo Lung Project.

Authors:  V Paul Doria-Rose; Pamela M Marcus
Journal:  Lung Cancer       Date:  2008-06-30       Impact factor: 5.705

7.  The impact of marriage on bladder cancer mortality.

Authors:  Jason L Nelles; Sue A Joseph; Badrinath R Konety
Journal:  Urol Oncol       Date:  2008-07-14       Impact factor: 3.498

8.  Effects of misattribution in assigning cause of death on prostate cancer mortality rates.

Authors:  Richard M Hoffman; S Noell Stone; William C Hunt; Charles R Key; Frank D Gilliland
Journal:  Ann Epidemiol       Date:  2003-07       Impact factor: 3.797

9.  Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program.

Authors:  Anne M Lachiewicz; Marianne Berwick; Charles L Wiggins; Nancy E Thomas
Journal:  Arch Dermatol       Date:  2008-04

10.  Accuracy of cancer death certificates and its effect on cancer mortality statistics.

Authors:  C Percy; E Stanek; L Gloeckler
Journal:  Am J Public Health       Date:  1981-03       Impact factor: 9.308

View more
  29 in total

1.  Antineoplastic Treatment of Advanced-Stage Non-Small-Cell Lung Cancer: Treatment, Survival, and Spending (2000 to 2011).

Authors:  Cathy J Bradley; K Robin Yabroff; Angela B Mariotto; Christopher Zeruto; Quyen Tran; Joan L Warren
Journal:  J Clin Oncol       Date:  2017-01-03       Impact factor: 44.544

2.  Cause-specific effects of radiotherapy and lymphadenectomy in stage I-II endometrial cancer: a population-based study.

Authors:  Loren K Mell; Ruben Carmona; Sachin Gulaya; Tina Lu; John Wu; Cheryl C Saenz; Florin Vaida
Journal:  J Natl Cancer Inst       Date:  2013-10-11       Impact factor: 13.506

3.  Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study.

Authors:  Timothy J Daskivich; Kang-Hsien Fan; Tatsuki Koyama; Peter C Albertsen; Michael Goodman; Ann S Hamilton; Richard M Hoffman; Janet L Stanford; Antoinette M Stroup; Mark S Litwin; David F Penson
Journal:  Urology       Date:  2014-09-26       Impact factor: 2.649

4.  Risk and timing of cardiovascular death among patients with myelodysplastic syndromes.

Authors:  Andrew M Brunner; Traci M Blonquist; Gabriela S Hobbs; Philip C Amrein; Donna S Neuberg; David P Steensma; Gregory A Abel; Amir T Fathi
Journal:  Blood Adv       Date:  2017-10-18

5.  A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease.

Authors:  Michael J Overman; Chung-Yuan Hu; Scott Kopetz; James L Abbruzzese; Robert A Wolff; George J Chang
Journal:  Ann Surg Oncol       Date:  2011-12-21       Impact factor: 5.344

6.  End-of-Life Medical Costs of Medicaid Cancer Patients.

Authors:  Florence K L Tangka; Sujha Subramanian; Susan A Sabatino; David H Howard; Susan Haber; Sonja Hoover; Lisa C Richardson
Journal:  Health Serv Res       Date:  2014-11-25       Impact factor: 3.402

7.  Misclassification of the actual causes of death and its impact on analysis: A case study in non-small cell lung cancer.

Authors:  Kay See Tan
Journal:  Lung Cancer       Date:  2019-05-16       Impact factor: 5.705

8.  Do diagnostic and treatment delays for colorectal cancer increase risk of death?

Authors:  Sandi L Pruitt; Amy Jo Harzke; Nicholas O Davidson; Mario Schootman
Journal:  Cancer Causes Control       Date:  2013-02-28       Impact factor: 2.506

9.  Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.

Authors:  Ruben Carmona; Kaveh Zakeri; Garrett Green; Lindsay Hwang; Sachin Gulaya; Beibei Xu; Rohan Verma; Casey W Williamson; Daniel P Triplett; Brent S Rose; Hanjie Shen; Florin Vaida; James D Murphy; Loren K Mell
Journal:  J Clin Oncol       Date:  2016-02-16       Impact factor: 44.544

10.  Hereditary Pancreatitis in the United States: Survival and Rates of Pancreatic Cancer.

Authors:  Celeste A Shelton; Chandraprakash Umapathy; Kimberly Stello; Dhiraj Yadav; David C Whitcomb
Journal:  Am J Gastroenterol       Date:  2018-07-18       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.